MedTrace Logo

European Active Surveillance Study for Intrauterine Devices

NCT00461175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63194

Last updated 2015-07-17

Study results available
· View outcomes & findings →

Summary

The primary objective of the study is to assess the risks of intrauterine device (IUD) use in a study population that is representative for the actual users of the individual IUDs. The primary clinical outcome of interest is the uterine perforation rate.

Conditions

  • Uterine Perforation

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Center for Epidemiology and Health Research, Germany

    lead OTHER

Principal Investigators

  • Klaas Heinemann, MD, PhD · Center for Epidemiology and Health Research, Germany

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2012-05-31
Completion
2013-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00461175 on ClinicalTrials.gov